Reference
Katayama K, et al. Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy. Gan to Kagaku Ryoho 40: 655-658, No. 5, May 2013 [Japanese; summarised from a translation] - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1618, 29 (2016). https://doi.org/10.1007/s40278-016-21034-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-21034-2